341 related articles for article (PubMed ID: 22621963)
1. Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-Study.
Banek S; Schwentner C; Täger D; Pesch B; Nasterlack M; Leng G; Gawrych K; Bonberg N; Johnen G; Kluckert M; Gakis G; Todenhöfer T; Hennenlotter J; Brüning T; Stenzl A;
Urol Oncol; 2013 Nov; 31(8):1656-62. PubMed ID: 22621963
[TBL] [Abstract][Full Text] [Related]
2. Nuclear matrix protein-22: a prospective evaluation in a population at risk for bladder cancer. Results from the UroScreen study.
Huber S; Schwentner C; Taeger D; Pesch B; Nasterlack M; Leng G; Mayer T; Gawrych K; Bonberg N; Pelster M; Johnen G; Bontrup H; Wellhäusser H; Bierfreund HG; Wiens C; Bayer C; Eberle F; Scheuermann B; Kluckert M; Feil G; Brüning T; Stenzl A;
BJU Int; 2012 Sep; 110(5):699-708. PubMed ID: 22313585
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
Bonberg N; Taeger D; Gawrych K; Johnen G; Banek S; Schwentner C; Sievert KD; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Stenzl A; Behrens T; Brüning T; Pesch B;
BJU Int; 2013 Aug; 112(4):E372-82. PubMed ID: 23350736
[TBL] [Abstract][Full Text] [Related]
4. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
[TBL] [Abstract][Full Text] [Related]
5. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the sensitivity and specificity of urine cytology, urinary nuclear matrix protein-22 and multitarget fluorescence in situ hybridization assay in the detection of bladder cancer.
Kehinde EO; Al-Mulla F; Kapila K; Anim JT
Scand J Urol Nephrol; 2011 Mar; 45(2):113-21. PubMed ID: 21091091
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology.
Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X
Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689
[TBL] [Abstract][Full Text] [Related]
8. Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology.
Youssef RF; Schlomer BJ; Ho R; Sagalowsky AI; Ashfaq R; Lotan Y
Urol Oncol; 2012; 30(3):273-7. PubMed ID: 20451422
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
10. Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder.
Lotan Y; Bensalah K; Ruddell T; Shariat SF; Sagalowsky AI; Ashfaq R
J Urol; 2008 Jun; 179(6):2164-9. PubMed ID: 18423745
[TBL] [Abstract][Full Text] [Related]
11. Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer.
Junker K; Fritsch T; Hartmann A; Schulze W; Schubert J
Cytogenet Genome Res; 2006; 114(3-4):279-83. PubMed ID: 16954667
[TBL] [Abstract][Full Text] [Related]
12. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
[TBL] [Abstract][Full Text] [Related]
13. The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.
Karnwal A; Venegas R; Shuch B; Bassett J; Rajfer J; Reznichek R
Can J Urol; 2010 Apr; 17(2):5077-81. PubMed ID: 20398445
[TBL] [Abstract][Full Text] [Related]
14. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
[TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis of fluorescence in situ hybridization and cytology for diagnosis of bladder cancer].
Yang MG; Zhao XK; Hou Y; Xiao N
Ai Zheng; 2009 Jun; 28(6):655-62. PubMed ID: 19635207
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urine CYFRA 21-1 for the detection of primary and recurrent bladder carcinoma.
Nisman B; Barak V; Shapiro A; Golijanin D; Peretz T; Pode D
Cancer; 2002 Jun; 94(11):2914-22. PubMed ID: 12115379
[TBL] [Abstract][Full Text] [Related]
17. [Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].
Asali MG; Kaneti J; Manor E
Harefuah; 2007 Dec; 146(12):914-9, 1000. PubMed ID: 18254439
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
19. Clinical usefulness of fluorescence in situ hybridization for diagnosis and surveillance of bladder cancer.
Song MJ; Lee HM; Kim SH
Cancer Genet Cytogenet; 2010 Apr; 198(2):144-50. PubMed ID: 20362229
[TBL] [Abstract][Full Text] [Related]
20. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
